Markus Kosch/LinkedIn
May 28, 2025, 14:36
Daiichi Sankyo at ASCO 2025: Markus Kosch on Advancing Patient Outcomes Through Scientific Innovation
Markus Kosch, Head Oncology Europe and at Daiichi Sankyo Europe, shared a post on LinkedIn:
“In just two days, the global oncology community will gather in Chicago for ASCO 2025 – a moment to listen, learn, and engage with the partners that continues to transform cancer care around the world.
As a Platinum Sponsor, Daiichi Sankyo is proud to support this important event. But more than that, we see ASCO as an opportunity to connect – with healthcare professionals, researchers, and partners who share a commitment to advancing patient outcomes through scientific innovation.
Our focus this year is clear: Deepen scientific dialogue, strengthen partnerships, and bring insights home to drive meaningful change for the people who matter most – patients.
To all colleagues attending: thank you for representing our science and values on the global stage. And to those following from across the globe – your engagement will help carry these insights forward, where they can make a difference.
See you in Chicago!”
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
May 29, 2025, 14:15
May 29, 2025, 13:35
May 29, 2025, 13:11